Vasoproliferation and Antiproliferative Treatment Options in Pulmonary Arterial Hypertension

E-ISSN： 2212-3962|4|2|142-149

ISSN： 1574-8901

Source： Recent Patents on Cardiovascular Drug Discovery, Vol.4, Iss.2, 2009-06, pp. : 142-149

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current Treatment of the Pulmonary Arterial Hypertension

Current Respiratory Medicine Reviews, Vol. 3, Iss. 2, 2007-05 ,pp. : 129-134

Bentham Science Publishers

Access to resources Recommend Favorite

Pulmonary Arterial Hypertension: A Comprehensive Review of Pharmacological Treatment

By Erika Berman Rosenzweig Barst Robyn J.

Treatments in Respiratory Medicine, Vol. 5, Iss. 2, 2006-01 ,pp. : 117-127

Adis International

Access to resources Recommend Favorite

Evaluation of imatinib mesylate in the treatment of pulmonary arterial hypertension

By Chhina Mantej K Nargues Weir Grant Geraldine M Nathan Steven D

Future Cardiology, Vol. 6, Iss. 1, 2010-01 ,pp. : 19-35

Future Medicine

Access to resources Recommend Favorite

Prostanoids for Pulmonary Arterial Hypertension

By Galiè N. Manes A. Branzi A.

American Journal of Respiratory Medicine, Vol. 2, Iss. 2, 2003-01 ,pp. : 123-137

Adis International

Access to resources Recommend Favorite

Ambrisentan for pulmonary arterial hypertension

By Rubin Lewis J Dufton Christopher Gerber Michael J

Future Cardiology, Vol. 1, Iss. 4, 2005-07 ,pp. : 425-432

Future Medicine

Access to resources Recommend Favorite